Network origin in Raymond C. Egan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Raymond C. Egan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOSYNTECH, INC. | Pharmaceuticals: Major | Chairman | |
| BELLUS HEALTH | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NEPTUNE WELLNESS SOLUTIONS INC. | Pharmaceuticals: Other | Public Communications Contact | |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Medical Specialties | Corporate Officer/Principal | |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director/Board Member | |
| BETTERLIFE PHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| TESARO INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
| McGill University | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman | |
Fonds de Solidarité FTQ
 Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Investment Managers | Private Equity Investor | |
| University of Louisville | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
| University of Montréal | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Institut d'Études Politiques d'Aix-en-Provence | College/University | Undergraduate Degree | |
| University of Strasbourg | College/University | Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Clinical Cancer Research | Corporate Officer/Principal | ||
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Duke University Medical Center | College/University | Corporate Officer/Principal | |
| MEDMIRA INC. | Medical Specialties | Director/Board Member | |
| DaIIchi Pharma Holdings, Inc. | Chief Tech/Sci/R&D Officer | ||
| Carolina Student Biotechnology Network | Director/Board Member | ||
| Sennes Drug Innovations, Inc. | Chief Executive Officer | ||
| SANUWAVE HEALTH, INC. | Medical Specialties | Director of Finance/CFO | |
| Pacific Biopharma Associates | Founder | ||
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale School of Medicine | College/University | Corporate Officer/Principal | |
Isologic Innovative Radiopharmaceuticals Ltd.
 Isologic Innovative Radiopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Isologic Innovative Radiopharmaceuticals Ltd. operates as a radiopharmaceutical company. The company is headquartered in Burlington, Canada. | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Louisville School of Medicine | College/University | Doctorate Degree | |
| CONVERGE TECHNOLOGY SOLUTIONS CORP. | Packaged Software | Director/Board Member | |
Epi-Cure Pharmaceuticals, Inc.
 Epi-Cure Pharmaceuticals, Inc. BiotechnologyHealth Technology Epi-Cure Pharmaceuticals, Inc. is a private company that focuses on researching and developing pharmaceutical products. The company is based in Weston, MA. The company was founded in 2016 by Robert E. Martell. | Biotechnology | Founder | |
| SPROUT AI INC. | Trucks/Construction/Farm Machinery | Director/Board Member | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 29 |
| Canada | 19 |
| France | 3 |
| United Kingdom | 2 |
| Panama | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 11 |
| Health Services | 4 |
| Finance | 3 |
| Non-Energy Minerals | 2 |
Operational
| Director/Board Member | 72 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 17 |
| Chairman | 16 |
| Chief Tech/Sci/R&D Officer | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Louis P. Lacasse | 26 |
| David Drutz | 24 |
| Jay Moorin | 21 |
| Martin Godbout | 21 |
| Robert Martell | 18 |
| Toni Rinow | 14 |
| Colin R. Mallet | 12 |
| André Archimbaud | 10 |
| Charles Grubsztajn | 7 |
| Daniel Delorme | 5 |
| Robert E. Déziel | 4 |
| Klaus B. Kepper | 4 |
| Michel Drouin | 2 |
| Nafsika Dakou | 1 |
- Stock Market
- Insiders
- Raymond C. Egan
- Company connections
